A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
Public ClinicalTrials.gov record NCT06578585. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomized, Double-blind, Placebo-controlled Trial Investigating the Safety and Tolerability of Lu AG09222 When Coadministered With Ubrogepant in Participants With Migraine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main goal of this trial is to learn more about the safety and tolerability of Lu AG09222 when taken together with ubrogepant. This includes looking for any new or worsening medical issues the participants have with the treatment. During the trial, participants with migraine will receive ubrogepant oral tablets and an injection of either Lu AG09222 or a placebo.
Study identification
- NCT ID
- NCT06578585
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 12, 2024
- Primary completion
- Jul 10, 2025
- Completion
- Jul 10, 2025
- Last update posted
- Oct 13, 2025
2024 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Neuroscience Solutions | Orlando | Florida | 32801 | — |
| NeuroTrials Research | Atlanta | Georgia | 30328 | — |
| Future Search Trials | Austin | Texas | 78731 | — |
| Elevate Clinical Research | Seabrook | Texas | 77586 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Migraine trials
Other public records listing Migraine. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792291: Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot Not yet recruiting
- NCT07764783: Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine Not yet recruiting
- NCT05755945: A Study of Wearable Devices to Predict Migraines Active, not recruiting
- NCT07754266: Headache Ear Auditory Dizziness Sinus (HEADS) Registry Recruiting
- NCT07616128: Study of EVO756 in Adults With Migraine Recruiting
- NCT07645924: A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06578585, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06578585 live on ClinicalTrials.gov.